Brind.

Entities / Company

Ascendis Pharma (Denmark).

company in Copenhagen, Denmark

Seen in 6 reportsLast reported May 20

Reports this week: 0
Active events: 0
Connections: 8

What's happening

Gone quiet

No new reports in 90+ days

Morgan Stanley initiated coverage on July 11, 2025, with a Buy rating, noting that Voxzogo is BioMarin's therapy for achondroplasia and that TransCon CNP could be a competitor.

Some support1 report

History

Events by the month they began

June 2026

1 event

Jun 8, 2026Morgan Stanley initiated coverage on July 11, 2025, with a Buy rating, noting that Voxzogo is BioMarin's therapy for achondroplasia and that TransCon CNP could be a competitor.